Wellness
NAD+
Illustrative packaging. Actual dispensed packaging may differ.
Get to know NAD+
Explore information about the NAD+ formulation offered through SUROS Rx. Discuss the available evidence, potential risks, and alternatives with your provider before making a treatment decision.
Pricing will be published before online visits open.
A prescription is issued only if a licensed provider determines treatment is appropriate.
Review treatment-specific information with your provider.
Commonly reported effects may include injection-site redness, warmth, or mild discomfort and temporary flushing.
View important safety informationWhat happens next
- 01
Share your history
Complete an online visit with your health history, medications, and goals.
- 02
Provider review
A licensed provider reviews your information and discusses appropriate next steps.
- 03
Ongoing guidance
If prescribed, follow your care plan. Patient services will be available when online visits open.
Common questions about NAD+
Should I expect an immediate change?
Do not assume a particular result or timeline. Ask your provider about the evidence, uncertainties, and goals for the specific formulation being discussed.
Does an online visit guarantee a prescription?
No. A licensed provider reviews your information and determines whether treatment is appropriate. A different option—or no prescription—may be recommended.
How do I use the medication if it is prescribed?
Follow the instructions supplied by your provider and dispensing pharmacy. Contact your care team if anything is unclear before using it. Do not use an illustrative website vial to determine a dose.
What will it cost?
Pricing will be published before online visits open.
How do I get help during treatment?
For general website or account questions, email support@surosrx.com. Patient services will be available when online visits open. Do not email sensitive medical details to general support.
Molecular profile
- Formula
- C₂₁H₂₇N₇O₁₄P₂
- Molecular weight
- 663.43 g/mol
- CAS number
- 53-84-9
- Sequence
- Not applicable — small molecule
Important Safety Information
Review the information below and discuss questions with your provider. This page does not replace your prescription instructions or individualized medical advice.
Compounded NAD+ is not FDA-approved. Its safety and effectiveness have not been established through large-scale human clinical trials of the compounded formulation, and product strength and quality may vary by compounding pharmacy. Use during pregnancy or breastfeeding, or in patients managing a serious or active medical condition, should be discussed with a provider first.
Reported effects (from available research and clinical reports — not an FDA-established safety profile):
- Injection-site redness, warmth, or mild discomfort
- Temporary flushing
- Headache
Always use NAD+ exactly as prescribed, and discuss any questions or side effects with your healthcare provider.
